3-BOC-7-OXO-3,9-DIAZABICYCLO[3.3.1]NONANE, 95.0%, 250mg

3-(3-Nitrophenyl)-3-oxopropanenitrile, 95.0%, 250mg

4-(2-methoxyphenyl)phenylboronic acid, 98%, 500mg

4-(4-oxoquinazolin-3(4H)-yl)benzoic acid, 95.0%, 500mg

N2-Acetyl acyclovir, 98%, 1g

2-((2R,3R)-4-(Anthracen-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine, 97%, 1g

5-Bromo-2-phenoxypyridine, 95.0%, 250mg

4-Bromo-1-iodo-2-nitrobenzene, 97.0%, 100g

Methyl 1,6-naphthyridine-2-carboxylate, 95.0%, 10g

2-(2-Aminoethylamino)ethanol, min 98%, for synthesis, 1 L, glass packaging

(E)-4-(4-Fluorophenyl)-4-oxobut-2-enoic acid, 97%, 5g

2,5-Dioxopyrrolidin-1-yl 19-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-17-oxo-4,7,10,13-tetraoxa-16-azanonadecan-1-oate, 99%, 100mg

N-Methyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 95.0%, 5g